Cargando…
Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study
Based on its wide range of immunosuppressive properties, hydroxychloroquine (HCQ) is used for the treatment of several autoimmune diseases. Limited literature is available on the relationship between HCQ concentration and its immunosuppressive effect. To gain insight in this relationship, we perform...
Autores principales: | in ‘t Veld, Aliede E., Grievink, Hendrika W., van der Plas, Johan L., Eveleens Maarse, Boukje C., van Kraaij, Sebastiaan J. W., Woutman, Tess D., Schoonakker, Mascha, Klarenbeek, Naomi B., de Kam, Marieke L., Kamerling, Ingrid M. C., Jansen, Manon A. A., Moerland, Matthijs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945836/ https://www.ncbi.nlm.nih.gov/pubmed/36811819 http://dx.doi.org/10.1007/s12026-023-09367-3 |
Ejemplares similares
-
Effect of hydroxychloroquine on the cardiac ventricular repolarization: A randomized clinical trial
por: Eveleens Maarse, Boukje C., et al.
Publicado: (2021) -
Antimicrobial Peptide Omiganan Enhances Interferon Responses to Endosomal Toll‐Like Receptor Ligands in Human Peripheral Blood Mononuclear Cells
por: Grievink, Hendrika W., et al.
Publicado: (2020) -
Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19
por: in ‘t Veld, Aliede E., et al.
Publicado: (2021) -
Erratum to “Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19”
por: in ‘t Veld, Aliede E., et al.
Publicado: (2021) -
Monitoring of Ex Vivo Cyclosporin a Activity in Healthy Volunteers Using T Cell Function Assays in Relation to Whole Blood and Cellular Pharmacokinetics
por: in ’t Veld, Aliede E., et al.
Publicado: (2022)